← Back to Search

Device

Indwelling foley catheter for Urinary Retention

N/A
Waitlist Available
Led By Craig Della Valle, MD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any patient >18 years of age scheduled for an inpatient primary hip or knee replacement
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 weeks after surgery
Awards & highlights

Study Summary

Urinary retention is a known complication following surgical procedures, with a theoretical increased risk in patients receiving neuraxial anesthesia due to a decreased ability to sense bladder distension. Urinary retention is associated with adverse events including bladder atony, increased post void residuals, and postoperative urinary tract infection. Treatment of urinary retention involves intermittent or indwelling urinary catheter placement, both of which are associated with an increased prevalence of postoperative urinary tract infection. There currently is no consensus whether the use of a urinary catheter in elective joint arthroplasty with neuraxial anesthesia decreases the risk of urinary retention. The prevalence of retention reported in the literature varies widely with reports anywhere from 0% to 75% in patients with early removal of a catheter or after procedures performed without a catheter. The goal of this study is to determine whether the routine use of an indwelling urinary catheter decreases the rate of postoperative urinary retention in patients undergoing elective joint arthroplasty.

Eligible Conditions
  • Urinary Retention
  • Total Knee Replacement
  • Total Hip Replacement

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~while inpatient at hospital, immediately following surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and while inpatient at hospital, immediately following surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Patients Who Developed Postoperative Urinary Retention (POUR), Unable to Void a Volume Greater Than or Equal to 30ml/hr
Secondary outcome measures
Straight Catheterization Required While Inpatient Following Total Joint Arthroplasty
Urinary Tract Infections (UTI) as Complication up to 3 Weeks Following Total Joint Arthroplasty

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Indwelling foley catheterExperimental Treatment1 Intervention
Short-term indwelling foley catheter
Group II: No Foley catheterPlacebo Group1 Intervention
No foley catheter
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indwelling foley catheter
2020
N/A
~390

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,113 Total Patients Enrolled
1 Trials studying Urinary Retention
7 Patients Enrolled for Urinary Retention
Craig Della Valle, MDPrincipal InvestigatorRush University Medical Center
9 Previous Clinical Trials
1,800 Total Patients Enrolled

Frequently Asked Questions

~88 spots leftby Apr 2025